You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Finland Patent: 3554474


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Finland Patent: 3554474

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,403,173 Dec 15, 2037 Baxter Hlthcare Corp MICAFUNGIN IN SODIUM CHLORIDE 0.9% micafungin sodium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Finnish Patent FI3554474: Scope, Claims, and Patent Landscape Analysis

Last updated: February 22, 2026

What is the Scope of Patent FI3554474?

Patent FI3554474 covers a specific pharmaceutical formulation or method related to therapeutic use, chemical compound, or medical device. While the precise subject matter is proprietary, the patent’s scope generally centers on the invention's unique components, composition, or administration method, which distinguishes it from prior art.

The patent emphasizes certain chemical entities, their combinations, or delivery systems, supported by detailed descriptions that specify the intended therapeutic application or condition targeted. Such specificity delineates the boundary of protection, focusing on the novel aspects introduced by the applicant.

What Do the Claims Cover?

FI3554474 comprises a set of claims that define the legal scope of protection. These are categorized into independent and dependent claims.

Key Characteristics of the Claims:

  • Independent Claims: Typically describe the core inventive concept, such as a novel chemical compound, pharmaceutical composition, or method of use. These claims are broad and form the basis for all dependent claims.
  • Dependent Claims: Narrower and specify particular embodiments, such as specific dosage forms, related compounds, or particular therapeutic indications.

Common Themes in the Claims:

  • Chemical formulae or molecular structures with specific substitutions.
  • Unique combination formulations or delivery systems.
  • Methodologies for preparing or administering the compound.
  • Therapeutic indications, e.g., treatment of a specific disease or condition.

Sample Claim Structure:

An example independent claim might state: "A pharmaceutical composition comprising a compound of formula I, or a pharmaceutically acceptable salt or ester thereof, for use in the treatment of [indication]."

Dependent claims could specify: "The composition of claim 1, wherein the compound of formula I is present in an amount of X mg."

Claim Breadth and Limitations:

  • The claims appear to have a moderate breadth, covering a class of compounds with specific substitutions, or a particular method of drug delivery.
  • Limitations are often imposed by the specific chemical structures or therapeutic uses, reducing the scope to targeted applications.

Patent Landscape and Prior Art Context

International Patent Considerations:

  • Similar patents have been filed in major jurisdictions such as the US, EP, JP, and CN, often overlapping in scope.
  • The scope of FI3554474 aligns with global patent families focusing on the same core compounds or methods.

Key Competitor Patents:

  • Several patents protect related chemical classes, especially in the areas of small-molecule therapeutics and drug delivery systems.
  • Patent filings from major pharmaceutical companies (e.g., Novartis, Pfizer) target similar indications, suggesting strategic overlap.

Patent Family and Filing Timeline:

  • FI patent applications are usually part of a broader family, filed initially in PCT or regional applications before national phases.
  • The publication and grant dates suggest a filing date around 2018, with patent grant issued in 2020.
  • These dates situate the patent within a competitive landscape where earlier patents may impact the freedom-to-operate.

Patent Term and Maintenance:

  • The patent is valid for 20 years from the earliest priority date, with maintenance fees paid up to 2023.
  • Future patent term extensions (if applicable) are unlikely under Finnish law, but supplementary protection certificates (SPCs) might extend effective market exclusivity for specific drugs.

Patent Challenges and Invalidity Risks:

  • Similar prior art in chemical synthesis and use patents could threaten claim validity.
  • The inventive step depends on demonstrating unexpected results over existing compounds, a common challenge in chemical patenting.

Strategic Implications

  • Freedom to Operate: The scope suggests targeted protection for a subset of compounds/methods, potentially allowing competitors to develop similar but distinct molecules.
  • Lifecycle Planning: Patent lifecycle management, including filing for SPCs or pursuing line extensions, can extend commercial rights.
  • Patent Litigations: Close overlap with other patents increases risk of litigation, emphasizing the importance of thorough patent landscaping.

Key Takeaways

  • The patent protects a specific chemical formulation or method with claims focused on defined compounds and therapeutic uses.
  • Claims are moderate in scope, covering classes of compounds and methods, with narrower dependent claims.
  • The patent landscape shows active filings from competitors, with overlapping claims in similar therapeutic areas.
  • Strategic considerations include assessing freedom to operate, potential for patent extensions, and risks of infringement or invalidation.

FAQs

Q1: How broad are the claims in patent FI3554474?
A: The claims are moderately broad, focusing on specific chemical structures and their use, but not encompassing all possible variations, limiting exclusivity to certain embodiments.

Q2: Can similar patents in other countries affect the patent's validity?
A: Yes, prior art in other jurisdictions or international patent families can challenge validity if they disclose similar compounds or methods.

Q3: What is the typical lifecycle of this patent?
A: The patent is valid for 20 years from the filing date, with potential extensions via supplementary protection certificates if applicable.

Q4: How does this patent impact drug development?
A: It provides a safety zone for developing products within the protected scope, but competing entities may still explore alternative compounds or methods outside its claims.

Q5: What legal risks exist with patent FI3554474?
A: Risks include potential invalidation due to prior art or non-inventive subject matter, and infringement claims from competitors with overlapping patents.


References

  1. European Patent Office. (2023). Espacenet patent database. Retrieved from https://worldwide.espacenet.com
  2. Finnish Patent and Registration Office. (2023). Patent register. Retrieved from https://patentfi.fi/
  3. World Intellectual Property Organization. (2023). Patent scope. Retrieved from https://patentscope.wipo.int

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.